Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hamblin

Showing results (41-50 of 864) with videos related to

Pageof 87
Sort By:
Drug Development Research|August 3, 2018
Can light-based approaches overcome antimicrobial resistance?Michael R Hamblin, Heidi Abrahamse
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|March 26, 2011
The immunosuppressive side of PDTPawel Mroz, Michael R Hamblin
Photomedicine and Laser Surgery|December 22, 2016
Transcranial Low-Level Laser (Light) Therapy for Brain InjuryConnor Thunshelle, Michael R Hamblin
The Biochemical Journal|February 11, 2016
New photosensitizers for photodynamic therapyHeidi Abrahamse, Michael R Hamblin
Antibiotics (Basel, Switzerland)|February 7, 2020
Oxygen-Independent Antimicrobial Photoinactivation: Type III Photochemical Mechanism?Michael R Hamblin, Heidi Abrahamse
Photobiomodulation, Photomedicine, and Laser Surgery|November 24, 2021
Photobiomodulation Therapy Mechanisms Beyond Cytochrome c OxidaseMichael R Hamblin, Ann Liebert
Photodiagnosis and Photodynamic Therapy|June 1, 2010
Can surgical site infections be treated by photodynamic therapy?Michael R Hamblin, Tianhong Dai
Future Medicinal Chemistry|September 24, 2019
Tetracyclines: light-activated antibiotics?Michael R Hamblin, Heidi Abrahamse
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|May 4, 2004
Photodynamic therapy: a new antimicrobial approach to infectious disease?Michael R Hamblin, Tayyaba Hasan
International Journal of Immunopathology and Pharmacology|September 17, 2005
Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation stateQ Liu, M R Hamblin
Pageof 87

Showing results (41-50 of 864) with videos related to

Sort By:
Pageof 87
Drug Development Research|August 3, 2018
Can light-based approaches overcome antimicrobial resistance?Michael R Hamblin, Heidi Abrahamse
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|March 26, 2011
The immunosuppressive side of PDTPawel Mroz, Michael R Hamblin
Photomedicine and Laser Surgery|December 22, 2016
Transcranial Low-Level Laser (Light) Therapy for Brain InjuryConnor Thunshelle, Michael R Hamblin
The Biochemical Journal|February 11, 2016
New photosensitizers for photodynamic therapyHeidi Abrahamse, Michael R Hamblin
Antibiotics (Basel, Switzerland)|February 7, 2020
Oxygen-Independent Antimicrobial Photoinactivation: Type III Photochemical Mechanism?Michael R Hamblin, Heidi Abrahamse
Photobiomodulation, Photomedicine, and Laser Surgery|November 24, 2021
Photobiomodulation Therapy Mechanisms Beyond Cytochrome c OxidaseMichael R Hamblin, Ann Liebert
Photodiagnosis and Photodynamic Therapy|June 1, 2010
Can surgical site infections be treated by photodynamic therapy?Michael R Hamblin, Tianhong Dai
Future Medicinal Chemistry|September 24, 2019
Tetracyclines: light-activated antibiotics?Michael R Hamblin, Heidi Abrahamse
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|May 4, 2004
Photodynamic therapy: a new antimicrobial approach to infectious disease?Michael R Hamblin, Tayyaba Hasan
International Journal of Immunopathology and Pharmacology|September 17, 2005
Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation stateQ Liu, M R Hamblin
Pageof 87